The glutamatergic system outside the CNS and in cancer biology.
about
Metabotropic glutamate receptors (mGlus) and cellular transformation.Metabotropic glutamate receptors as a new therapeutic target for malignant gliomasGlutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells.Glutamate and its receptors in cancerFOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells.Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole.Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling.The biology of the glutamatergic system and potential role in migraine.Ketamine attenuates osteoarthritis of the knee via modulation of inflammatory responses in a rabbit model.Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development.VGluT2 expression in painful Achilles and patellar tendinosis: evidence of local glutamate release by tenocytes.The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor.Role of the nervous system in cancer metastasis.Neuroexcitatory targets in the female reproductive system of the nonhuman primate (Macaca fascicularis).NMDA receptors mediate contractile responses in human airway smooth muscle cells.Tumor progression: the neuronal input.Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma
P2860
Q30487265-DDCDB729-0322-47FB-8DE2-F3A7F82C120CQ33591900-122262AE-E2D1-4CB2-B005-F7E56C809358Q33730882-DFF41EBD-C067-43AD-82BA-0ABE8F715911Q34048497-35A1F2FF-08CC-468E-9404-DF139F00D4F2Q35013518-0ACD0B04-9BB2-4A41-A724-943ABEA55695Q35216875-4102F931-2004-4695-8F93-BBC335B5C19DQ35720701-66485F05-A5AF-4579-87AD-830B35B8FB88Q36288488-CEBD7CDB-CA23-4938-BE8E-55B407C931F7Q36390918-6D09CC4A-8B03-420A-9CBF-31F1881F09AFQ36816562-BF3ADDBD-B8B8-44A5-8FEB-2722A059B8FDQ36931350-36C2DB15-D781-43A5-A169-ECA94EA6808EQ37121338-75038392-7B35-4D7F-8344-8E82831EAB82Q37627169-32BD8174-6BE9-4055-B4BB-ECFA274C3B39Q37633258-E8234EA3-1695-4BE1-B3C8-FD97FB4D2999Q38192495-FE43D049-4ECB-4A7E-8E54-C9B507992ED7Q38927564-40261A39-53A6-4AF5-9E78-2DCAD04C6985Q39914415-5ED7261B-C81F-4484-8E30-9204FF3BF850Q46643632-1F7034D4-4628-40E8-B6A1-0EFA6705C059Q51639133-5DCD4803-9D79-4A0A-8682-BD885BE7CAB6Q52318550-7B6C0F7D-E6EB-491E-A818-BFAEDE298A6FQ58765770-42E79A9C-A99C-40AE-A67F-55FFC7DCD9A5
P2860
The glutamatergic system outside the CNS and in cancer biology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The glutamatergic system outside the CNS and in cancer biology.
@ast
The glutamatergic system outside the CNS and in cancer biology.
@en
type
label
The glutamatergic system outside the CNS and in cancer biology.
@ast
The glutamatergic system outside the CNS and in cancer biology.
@en
prefLabel
The glutamatergic system outside the CNS and in cancer biology.
@ast
The glutamatergic system outside the CNS and in cancer biology.
@en
P2093
P2860
P1476
The glutamatergic system outside the CNS and in cancer biology.
@en
P2093
Michael Koutsilieris
Niki Kalariti
Nikos Pissimissis
P2860
P304
P356
10.1517/13543784.14.12.1487
P407
P577
2005-12-01T00:00:00Z